BioCentury
ARTICLE | Financial News

Amphastar sets IPO range

June 14, 2014 12:40 AM UTC

Generics company Amphastar Pharmaceuticals Inc. (Rancho Cucamonga, Calif.) amended its IPO on NASDAQ and now hopes to sell 4 million shares at $10-$12. At the $11 midpoint, the company would raise $44 million and be valued at $470.4 million. A selling shareholder also plans to offer 3.4 million shares. Jefferies; BMO Capital Markets; Piper Jaffray; and Needham are underwriters. ...